Radiation Oncology

Papers
(The H4-Index of Radiation Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent60
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer58
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia55
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma52
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial51
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer48
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy45
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)41
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p41
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer41
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study40
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review37
Correction to: 125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts37
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis36
Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome35
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery34
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis33
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov32
Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI32
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy32
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy32
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost30
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer30
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study28
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors28
Radiotherapy refusal in breast cancer with breast-conserving surgery28
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma27
0.18480801582336